InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
T+90 hit rate
50%
T+90 mean return
-15.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Regan Barry J., Chief Operating Officer. Insider active across 1 company, notably DEXCOM INC. Aggregated, 14 filings have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €2.5m. Activity tracked since 22 November 2021. The latest transaction was filed on 18 December 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
1,675 shares@ US$121.85033.9% of flowCommon StockSEC:0001093557-23-000252:0
4,106 shares@ US$104.0638.2% of flowCommon StockSEC:0001093557-23-000229:0
2,019 shares@ US$95.223.8% of flowCommon StockSEC:0001093557-23-000224:0
1,989 shares@ US$128.054.8% of flowCommon StockSEC:0001093557-23-000162:0
2,214 shares@ US$124.505.3% of flowCommon StockSEC:0001093557-23-000109:0
2,406 shares@ US$111.3995.3% of flowCommon StockSEC:0001093557-23-000081:0
18,776 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-23-000059:0
2,213 shares@ US$106.124.5% of flowCommon StockSEC:0001093557-23-000016:0
3,781 shares@ US$112.62048.6% of flowCommon StockSEC:0001093557-22-000178:0
1,106 shares@ US$500.000.0020% mcap18.8% of flowCommon StockSEC:0001093557-22-000078:0
4,984 shares@ US$0.0010.0000% mcap0.0% of flowCommon StockSEC:0001093557-22-000052:0
1,671 shares@ US$0.0010.0000% mcap0.0% of flowCommon StockSEC:0001093557-21-000286:0
1,214 shares@ US$563.930.0024% mcap22.8% of flowCommon StockSEC:0001093557-21-000274:0
837 shares@ US$638.650.0019% mcap17.8% of flowCommon StockSEC:0001093557-21-000263:0
14 of 14 declarations
About Regan Barry J.
Barry J. Regan is the Executive Vice President of Operations at Dexcom Inc. As EVP, he is responsible for managing the company's global operations, specializing in glucose monitoring technologies. Dexcom Inc. is known for its innovations in healthcare. Regan plays a crucial role in optimizing operational processes and improving efficiency.
